It is entirely possible that the discrepancies found among these results concerning the effect of mutation allele CYP1B1 4326G on cancer risk might derive from the different ethnicities, subject numbers, and additional SNPs included in the studies. This evidence concerns the gene CYP1B1 and cancer.